Overall survival in TP53-mutated AML and MDS
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-06054-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Christian J Puzo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Mutation, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yale School of Medicine, New Haven, CT, USA.
- Department of Laboratory Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Laboratory Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA. Alexa.siddon@yale.edu.
- Department of Pathology, Yale School of Medicine, New Haven, CT, USA. Alexa.siddon@yale.edu.
Zitieren
APA
Puzo, C. J., Hager, K. M., Rinder, H. M., Weinberg, O. K., & Siddon, A. J. (2024). Overall survival in TP53-mutated AML and MDS. Annals of Hematology. https://doi.org/10.1007/s00277-024-06054-7
Vancouver
Puzo CJ, Hager KM, Rinder HM, Weinberg OK, Siddon AJ. Overall survival in TP53-mutated AML and MDS. Annals of Hematology. 2024. doi:10.1007/s00277-024-06054-7
BibTeX
@article{Puzo2024,
author = {Puzo, Christian J and Hager, Karl M and Rinder, Henry M and Weinberg, Olga K and Siddon, Alexa J},
title = {Overall survival in TP53-mutated AML and MDS},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06054-7}
}
EUVIMED